394 related articles for article (PubMed ID: 23348573)
21. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
Kim JH; Jung DY; Kim HR; Jung MH
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
[TBL] [Abstract][Full Text] [Related]
22. Identification of MIG12 as a mediator for stimulation of lipogenesis by LXR activation.
Inoue J; Yamasaki K; Ikeuchi E; Satoh S; Fujiwara Y; Nishimaki-Mogami T; Shimizu M; Sato R
Mol Endocrinol; 2011 Jun; 25(6):995-1005. PubMed ID: 21474539
[TBL] [Abstract][Full Text] [Related]
23. The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c.
Jakel H; Nowak M; Moitrot E; Dehondt H; Hum DW; Pennacchio LA; Fruchart-Najib J; Fruchart JC
J Biol Chem; 2004 Oct; 279(44):45462-9. PubMed ID: 15317819
[TBL] [Abstract][Full Text] [Related]
24. SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice.
Nguyen TTP; Kim DY; Lee YG; Lee YS; Truong XT; Lee JH; Song DK; Kwon TK; Park SH; Jung CH; Moon C; Osborne TF; Im SS; Jeon TI
Mol Cell; 2021 Sep; 81(18):3820-3832.e7. PubMed ID: 34233158
[TBL] [Abstract][Full Text] [Related]
25. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver.
Yamamoto T; Shimano H; Inoue N; Nakagawa Y; Matsuzaka T; Takahashi A; Yahagi N; Sone H; Suzuki H; Toyoshima H; Yamada N
J Biol Chem; 2007 Apr; 282(16):11687-95. PubMed ID: 17296605
[TBL] [Abstract][Full Text] [Related]
27. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor.
Inaba T; Matsuda M; Shimamura M; Takei N; Terasaka N; Ando Y; Yasumo H; Koishi R; Makishima M; Shimomura I
J Biol Chem; 2003 Jun; 278(24):21344-51. PubMed ID: 12672813
[TBL] [Abstract][Full Text] [Related]
28. LXR-SREBP-1c-phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size.
Okazaki H; Goldstein JL; Brown MS; Liang G
J Biol Chem; 2010 Feb; 285(9):6801-10. PubMed ID: 20037162
[TBL] [Abstract][Full Text] [Related]
29. RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.
Cui XB; Luan JN; Chen SY
J Biol Chem; 2015 Aug; 290(33):20387-95. PubMed ID: 26134570
[TBL] [Abstract][Full Text] [Related]
30. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.
Joseph SB; Laffitte BA; Patel PH; Watson MA; Matsukuma KE; Walczak R; Collins JL; Osborne TF; Tontonoz P
J Biol Chem; 2002 Mar; 277(13):11019-25. PubMed ID: 11790787
[TBL] [Abstract][Full Text] [Related]
31. The role of LXR alpha in goose primary hepatocyte lipogenesis.
Han C; Wang J; Li L; Wang L; Zhang Z
Mol Cell Biochem; 2009 Feb; 322(1-2):37-42. PubMed ID: 18975056
[TBL] [Abstract][Full Text] [Related]
32. Liver X receptor α induces 17β-hydroxysteroid dehydrogenase-13 expression through SREBP-1c.
Su W; Peng J; Li S; Dai YB; Wang CJ; Xu H; Gao M; Ruan XZ; Gustafsson JÅ; Guan YF; Zhang XY
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E357-E367. PubMed ID: 28270440
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis.
Kim YW; Kim YM; Yang YM; Kim TH; Hwang SJ; Lee JR; Kim SC; Kim SG
Free Radic Biol Med; 2010 Feb; 48(4):567-78. PubMed ID: 20005944
[TBL] [Abstract][Full Text] [Related]
34. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
Kay HY; Kim WD; Hwang SJ; Choi HS; Gilroy RK; Wan YJ; Kim SG
Antioxid Redox Signal; 2011 Oct; 15(8):2135-46. PubMed ID: 21504366
[TBL] [Abstract][Full Text] [Related]
35. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
[TBL] [Abstract][Full Text] [Related]
36. Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype.
Shen L; Cui A; Xue Y; Cui Y; Dong X; Gao Y; Yang H; Fang F; Chang Y
J Biol Chem; 2014 Aug; 289(34):23332-42. PubMed ID: 24993831
[TBL] [Abstract][Full Text] [Related]
37. SREBP-1-independent regulation of lipogenic gene expression in adipocytes.
Sekiya M; Yahagi N; Matsuzaka T; Takeuchi Y; Nakagawa Y; Takahashi H; Okazaki H; Iizuka Y; Ohashi K; Gotoda T; Ishibashi S; Nagai R; Yamazaki T; Kadowaki T; Yamada N; Osuga J; Shimano H
J Lipid Res; 2007 Jul; 48(7):1581-91. PubMed ID: 17456898
[TBL] [Abstract][Full Text] [Related]
38. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
[TBL] [Abstract][Full Text] [Related]
39. 20(S)-protopanaxatriol inhibits liver X receptor α-mediated expression of lipogenic genes in hepatocytes.
Oh GS; Yoon J; Lee GG; Oh WK; Kim SW
J Pharmacol Sci; 2015 Jun; 128(2):71-7. PubMed ID: 26109499
[TBL] [Abstract][Full Text] [Related]
40. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO
Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
